DJIA 18,135.72 38.82 0.21%
NASDAQ 4,982.81 15.67 0.32%
S&P 500 2,101.04 2.51 0.12%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

71.76 1.60 (2.28%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ISIS $71.76 2.28%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $70.44
Previous Close $70.16
Daily Range $70.25 - $72.99
52-Week Range $22.25 - $75.24
Market Cap $8.5B
P/E Ratio -212.61
Dividend (Yield) $0.00 (0.0%)
Volume 3,757,532
Average Daily Volume 3,015,718
Current FY EPS -$0.81




Drug Makers

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website:

News & Commentary Rss Feed

Pfizer Inc. Has a Growth Problem -- Here Are 3 Ways to Change That

This year will likely mark Pfizer's fifth consecutive year of revenue declines. But a quick solution to its growth concerns could lie within one (or more) of these three proposed fixes.

Biotech Stock Roundup: Orexigen Soars on Contrave Data, Amgen Scores in Study - Analyst Blog

Roche's Avastin Gets Positive Opinion for Cervical Cancer - Analyst Blog

Gilead's (GILD) HIV Drug Positive in 2 Phase III Studies - Analyst Blog

3 Stocks Dragging The Drugs Industry Downward

Morning Market Losers

Isis Pharmaceuticals (ISIS) Is Today's Unusual Social Activity Stock

Health Care Sector Update for 03/02/2015: PCRX, ISIS, XLRN

Benzinga's Top #PreMarket Losers

Whoa, a Profit for Isis Pharmaceuticals Inc.

Don't get too excited just yet.

See More ISIS News...

ISIS's Top Competitors

ISIS $71.76 (2.28%)
Current stock: ISIS
AMGN $159.60 (0.26%)
Current stock: AMGN
GILD $103.42 (0.34%)
Current stock: GILD
BIIB $425.61 (2.77%)
Current stock: BIIB